TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment

Relapse in multiple myeloma (MM) decreases therapy efficiency through unclear mechanisms of chemoresistance. Since our group previously demonstrated that heme oxygenase-1 (HO-1) and Toll-like receptor 4 (TLR4) are two signaling pathways protecting MM cells from the proteasome inhibitor bortezomib (B...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Grazia Scandura, Cesarina Giallongo, Fabrizio Puglisi, Alessandra Romano, Nunziatina Laura Parrinello, Tatiana Zuppelli, Lucia Longhitano, Sebastiano Giallongo, Michelino Di Rosa, Giuseppe Musumeci, Roberto Motterlini, Roberta Foresti, Giuseppe Alberto Palumbo, Giovanni Li Volti, Francesco Di Raimondo, Daniele Tibullo
格式: Artigo
語言:Inglês
出版: MDPI AG 2022-04-01
叢編:Antioxidants
主題:
multiple myeloma
TLR4/HO-1 crosstalk
mitochondria
bortezomib
在線閱讀:https://www.mdpi.com/2076-3921/11/4/767
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍